Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

29 Results

Guidelines and Advice

Treatment of Acute Myeloid Leukemia in Older Patients

Status: Archived
ID: 6-14

Dec 2008

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Drug

dexamethasone

Quick Link(s):

Patient Info Sheet

Jan 2018

Drug

prednisone

Quick Link(s):

Patient Info Sheet

Jan 2018

Statistical Reports

Ontario Cancer Statistics 2018

Jan 2018

Cancer facts

Many cancers caused by infections in Ontario are preventable

Jan 2018

Guidelines and Advice

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Status: Archived
ID: CED 8

Jul 2008

Guidelines and Advice

The Use of Imatinib Mesylate (GleevecTM) in Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Status: Archived
ID: CED 10

Sep 2008

Guidelines and Advice

Sorafenib for Advanced Hepatocellular Carcinoma

Status: Archived
ID: CED 7

Feb 2008

Guidelines and Advice

Patient Indications for Mohs Micrographic Surgery

Status: Current
ID: GL 8-11

Jan 2018

Guidelines and Advice

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Status: Archived
ID: CED 9

Aug 2008

Guidelines and Advice

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Status: Archived
ID: 1-13

Sep 2008

Pages